AI assistant
Sending…
CellaVision — Major Shareholding Notification 2010
Dec 3, 2010
3025_iss_2010-12-03_f42f13e5-4465-40f0-a311-89cf390db737.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Issuer CellaVision AB
Holder
Life Equity Sweden KB
Instrument
| Instrument | AK |
|---|---|
| Before the transaction | |
| Shares | 1,626,783 |
| Voting rights | 1,626,783 |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 03/12/2010 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 0 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 0 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total
Notes (other relevant informations according to law)
Life Equity KB har den 3 december 2010 låtit dela ut samtliga aktier i CellaVision AB (publ), org.nr. 556500-0998 ("CellaVision"), vilka innehades av Life Equity Sweden KB ("Fonden"), till fondens investerare.
Published
03/12/2010 12:58
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from CellaVision
AGM Information
2026
Apr 28
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 28
Interim / Quarterly Report
2026
Apr 24
Interim / Quarterly Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 16
Annual Report (ESEF)
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Interim / Quarterly Report
2026
Feb 5